CERT 241115 17.50C (CERT241115C17500) Stock Options, News & Quotes

US OptionsDetailed Quotes

CERT241115C17500

Watchlist

0.37
0.000.00%

15min DelayClose Nov 5 09:46 ET

0.00High0.00Low

Intraday

5D
Daily

News

Baird Maintains Certara(CERT.US) With Hold Rating, Cuts Target Price to $13
Moomoo NewsNov 5 07:31 ET · Ratings
Certara Is Maintained at Neutral by Baird
Dow JonesNov 5 07:22 ET · Ratings
United States Medical Writing Market Report 2024-2032, Featuring Profiles of Inclin, Parexel, Cardinal Health, MakroCare, Freyr Solutions, Banner Medical, IQVIA Holdings, Certara and Clinovo
Yahoo FinanceNov 5 07:16 ET
Certara Price Target Lowered to $13 From $18 at Baird
TipRanksNov 5 06:55 ET
Earnings Preview: Certara to Report Financial Results Post-market on November 06
Moomoo NewsOct 31 21:00 ET
Certara to Participate in the Stephens Annual Investment Conference
GlobeNewswireOct 28 16:15 ET

Comments

Moomoo AI

Mar 21 09:18

The fact that Certara is now generating some pre-tax profits from its prior investments is very encouraging. The promising trends warrant this stock for further investigation despite its current low returns compared to the industry average.

Returns At Certara (NASDAQ:CERT) Are On The Way Up

Moomoo AI

Dec 13, 2023 15:33

Acquisition of Applied BioMath by Certara could enhance QSP biosimulation adoption in life sciences, revolutionizing drug invention. This may impact the drug discovery process, improving decisions and reducing late stage attrition rates.

Press Release: Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Moomoo AI

Oct 31, 2023 06:27

Amid less promising revenue projections, Certara's surprisingly high P/S ratio indicates investor hopes for a business rebound. However, analysts remain skeptical, suggesting shareholders may face disappointment if the P/S ratio rebalances with growth outlook.

Certara, Inc.'s (NASDAQ:CERT) Price Is Out Of Tune With Revenues

Movers and Shakers

Aug 22, 2023 07:21

Columns Today's Pre-Market Stock Movers And Top Ratings: ZM, LOW, EMR, MDT and More

Pre-Market Stock Movers
Gapping up
$Fabrinet (FN.US)$
(Fabrinet surged 21% after its fiscal fourth-quarter results late Monday topped analysts' estimates. The advanced manufacturing services company posted non-GAAP earnings of $1.86 per share, greater than the $1.80 earnings per share expected by analysts polled by FactSet. Revenue came in at $655.9 million, greater than the $641.4 million consensus estimate.)
$Applovin (APP.US)$
...